Global Pharma & Biotech Summit 2022

Start:

Mon, 7 Nov 2022, 09:00

End:

Wed, 9 Nov 2022, 18:00

Website:

https://iii.hm/globalpharmabiotech2022

Hashtag:

#FTPharma

Venue:

Hybrid Event

Find Financial Times On Social Media

Exhibit

Symposia

Workshops

Organiser

Sponsor

The Global Pharma and Biotech Summit is the essential annual event for you to stay on top of the latest trends and innovations in life sciences. CEOs, policymakers and thought leaders from around the world will discuss what’s new in areas such as drug discovery, clinical trials and market access. Join us in-person and online and as we explore new frontiers for business and for healthcare.

Showing Leadership

What does a good workforce transformation strategy look like? How do pharma companies set ESG goals? How do CEOs make the big calls on where to focus investment?

Supporting Innovation

Will cross-industry collaboration continue beyond the pandemic? How is technology transforming R&D? What are the latest next-generation therapies?

Saving Lives

What does the rise of precision medicine look like? How can pharma companies become more patient-centric? How can high-cost treatments be made more accessible and affordable?

Why Attend?

Understand

how pharma’s role in healthcare is evolving through the emergence of new treatments and new partnerships.

Discover

new approaches to drug development with the potential to transform pipelines and bring products to market faster

Connect

with some of the biggest names in the industry to learn about the latest trends, exchange ideas and build relationships

THE SUPER EARLY BIRD
IN-PERSON PASS

Get access to in-person sessions and networking. Network and connect with your peers.

£1999 ~~£2199~~

REGISTER HERE

THE SUPER EARLY BIRD
DIGITAL PASS

Access to the live stream, Q&A and video on
demand.

£149 ~~£299~~

REGISTER HERE

Programme Available

Click Here!

Leadership, Healthcare, clinical trials, Life Sciences, patient-centric, drug discovery, R&D, Global Pharma & Biotech Summit 2022, innovations in life sciences, ESG goals, generation therapies